Monografie
Optimisation of congenital adrenal hyperplasia therapy in paediatric and foetal populations by leveraging pharmacometrics
- Sprache
-
Englisch
- Identifier
-
131300300X
- Thema
-
Kind; Hydrocortison; Cushing-Syndrom; Pharmakotherapie
- Beteiligte Personen und Organisationen
- DOI
-
10.17169/refubium-41316
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.01.2024, 11:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Novel therapeutic approaches for Congenital Adrenal Hyperplasia
Pharmacometric approaches to assess hydrocortisone therapy in paediatric patients with adrenal insufficiency
Incidence of adrenal insufficiency in paediatric, oncologic patients with fever during chemotherapy
Growth in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Drug therapy for low cardiac output syndrome in paediatric patients with open heart surgery: Characterisation, paediatric needs assessment and optimisation
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
Adrenarche and Puberty in Children with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Adrenal progeny and factors of adrenal differentiation
Adrenal progeny and factors of adrenal differentiation
Adrenal disorders
Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
Paediatric pathology
Novel therapeutic approaches for Congenital Adrenal Hyperplasia
Pharmacometric approaches to assess hydrocortisone therapy in paediatric patients with adrenal insufficiency
Incidence of adrenal insufficiency in paediatric, oncologic patients with fever during chemotherapy
Growth in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Drug therapy for low cardiac output syndrome in paediatric patients with open heart surgery: Characterisation, paediatric needs assessment and optimisation
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
Adrenarche and Puberty in Children with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Adrenal progeny and factors of adrenal differentiation
Adrenal progeny and factors of adrenal differentiation
Adrenal disorders
Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
Paediatric pathology
Novel therapeutic approaches for Congenital Adrenal Hyperplasia
Pharmacometric approaches to assess hydrocortisone therapy in paediatric patients with adrenal insufficiency
Incidence of adrenal insufficiency in paediatric, oncologic patients with fever during chemotherapy
Growth in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Drug therapy for low cardiac output syndrome in paediatric patients with open heart surgery: Characterisation, paediatric needs assessment and optimisation
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
Adrenarche and Puberty in Children with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Adrenal progeny and factors of adrenal differentiation
Adrenal progeny and factors of adrenal differentiation
Adrenal disorders
Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency